Switching to a salt substitute from regular sodium chloride significantly reduced the risks for stroke recurrence and death, offering patients a practical, low-cost therapeutic option, according to ...

BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of the ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like Jardiance or ...

Potassium supplements in salt were associated with reduced rates of recurrent stroke and mortality in a large-scale cluster randomized clinical trial involving patients in rural northern China.

People who experience an arterial ischemic stroke (AIS) or transient ischemic stroke (TIA) are at an increased risk of suffering a second stroke or other major adverse cardiovascular event (MACE), ...

Share on Pinterest Salt substitutes are a simple intervention that can help manage blood pressure and lower stroke risk. Maskot/Getty Images Salt substitutes may reduce stroke recurrence and death, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Recurrent stroke risk has declined over the past 2 ...

Surviving a stroke represents a significant health victory, but many survivors don’t realize they’ve entered a high-risk category for experiencing another event. Understanding why stroke lightning can ...

Large infarction in the middle cerebral artery (dark blue) New-onset dementia among stroke patients appears to be most prevalent after two or more strokes, indicating that providing the best possible ...

Cryptogenic stroke survivors who went on to get an insertable cardiac monitor (ICM) had a similar risk of recurrent stroke whether or not any atrial fibrillation (Afib, AF) ever turned up on ...

A new study has identified new genetic and molecular risk factors that may reveal new pathways for treating patients after they experience their first stroke. The study identified CCL27 and TNFRSF14, ...